These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15518770)

  • 1. Antiviral therapy for hepatitis B after kidney transplantation.
    Chan TM
    Transplant Proc; 2004 Sep; 36(7):2124-5. PubMed ID: 15518770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.
    Filik L; Karakayali H; Moray G; Dalgiç A; Emiroğlu R; Ozdemir N; Colak T; Gür G; Yilmaz U; Haberal M
    Transplant Proc; 2006 Mar; 38(2):496-8. PubMed ID: 16549158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries.
    Chan TM; Chapman J; Lee CJ; Morad Z; Ona ET; Park K; Pingle A; Rizvi SA; Shaheen FA; Sumethkul V; Tang XD; Watarai Y
    Transplant Proc; 2004 Sep; 36(7):2126-7. PubMed ID: 15518771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
    Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation.
    Kranz B; Vester U; Bonzel KE; Paul A; Gerken G; Hoyer PF
    Pediatr Transplant; 2006 May; 10(3):384-9. PubMed ID: 16677367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serological markers of hepatitis B virus after renal transplantation.
    Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.
    Kohmoto M; Enomoto M; Tamori A; Habu D; Takeda T; Kawada N; Sakaguchi H; Seki S; Shiomi S; Nishiguchi S
    J Med Virol; 2005 Feb; 75(2):235-9. PubMed ID: 15602726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.
    Joh JW; Lee HH; Park JW; Lee DH; Yoo BC; Lee KW; Kim SJ
    Transplant Proc; 2005 Mar; 37(2):1235-7. PubMed ID: 15848680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
    Zhang FK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D
    Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
    Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
    Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis B in liver transplant patients.
    Mohanty SR; Cotler SJ
    J Clin Gastroenterol; 2005 Jan; 39(1):58-63. PubMed ID: 15599213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.